Are These Biotechs Worth Checking Out? Coronado Biosciences Inc (CNDO), BioCryst Pharmaceuticals Inc (BCRX) and Oxis International Inc (OXIS)

Posted by admin April 1, 2015 0 Comment 729 views

New York, NY – GDP INSIDER  –  04/01/2015.

This article discusses three companies: Coronado Biosciences Inc (NASDAQ:CNDO), BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) and Oxis International Inc (OTCMKTS:OXIS)

Coronado Biosciences Inc (NASDAQ:CNDO) reversed its recent downward trend yesterday with the stock gaining 8.76% or $0.31 to close at $3.85 on heavy trading of 4.048 million shares, compared to its three month average trading volume of 0.880 million. The developer of novel immunotherapy biological agents to fight cancer saw the gains on no major news, although several analysts upgraded their outlook. The shares have been performing well so far this year with the stock up 57.78%, but with the stock just passing a bearish MACD crossover it is likely to fall back soon.

Do Coronado Biosciences Inc’s Technical Indicators Support More Gains? Read Our Free CNDO Analysis For A More Detailed Perspective.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) bounced back yesterday to climb 5.37% or $0.46 to close at $9.03 on active trading of 2.427 million shares. The developer of new drugs that block key disease causing enzymes got the boost after it announced that it had received a federal contract for its new experimental drug labeled BCX4430. The drug, which is just now entering the human testing phase, is designed to combat Ebola and the federal funding could increase its budget by up to an additional $35 million, making it a hold and potential long term buy.

Is BioCryst Pharmaceuticals Inc A Good Long Term Investment? Take A Closer Look With Free BCRX Analysis.

Oxis International Inc (OTCMKTS:OXIS) posted further gains yesterday to reach a 52 week high of $0.07 before falling back slightly with the stock finishing up gaining 18.68% or $0.0085 by the end of trading to close at $0.054. The researcher and developer of products to counteract the harmful effects of oxidative stress, has been climbing steadily since the end of last year, up 80% YTD. With shares just passing a bullish MACD crossover and RSI of 72.10, the stock looks to be heading for a higher trading range around $0.06, making it a hold for now.

Can Oxis International Inc Keep Climbing? Click Here For Free OXIS Analysis.

About UltimateStockAlerts provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment